Your session is about to expire
← Back to Search
Ketogenic Diet for Pancreatic Cancer
Study Summary
This trial will study whether the ketogenic diet can help cancer patients with chemotherapy.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I do not have any severe illnesses like serious heart conditions.I have had diabetic ketoacidosis in the past.I do not have any ongoing serious infections needing treatment.Your tumors can be measured using specific guidelines called RECIST 1.1.I do not have severe numbness or pain in my hands or feet.You have signs of cancer that has spread to the brain or spinal cord.You are expected to live for at least 12 more weeks.I have been cancer-free for over 2 years, except for specific non-threatening cancers.Your blood's ability to clot is within the normal range, or slightly above it. If you are taking blood-thinning medication, the doctor may decide if you can still participate in the study.My blood and organ functions are within normal ranges.My BMI is below 18, indicating severe malnutrition.I can follow the study's rules on birth control and pregnancy testing.I have not had major surgery in the last 4 weeks, except for a port-a-cath insertion.I haven't had treatments for my metastatic pancreatic disease yet.I have been diagnosed with Type 1 diabetes.Your albumin levels are lower than 3.0 g/dL.My pancreatic cancer has spread and hasn't been treated yet.I will not have unprotected sex during and for 6 months after the study.I am able to care for myself but may not be able to do active work.I am 18 years old or older.I have been diagnosed with HIV, hepatitis B, or hepatitis C.
- Group 1: Ketogenic (KD) + Triplet
- Group 2: Non-ketogenic + Triplet
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
In what quantity of healthcare institutions is this experiment being conducted?
"The study is currently calling for patients at 7 sites, with Morristown, Norwalk and Danbury among the locations. To optimize convenience, it's best to select a site that is close by your residence."
Are there any available spots for new participants in this trial?
"According to the data hosted on clinicaltrials.gov, this study is actively enrolling participants. The trial was initially available for review on December 2nd 2020 and its most recent update occurred June 9th 2022."
How many participants will the maximum capacity of this research accommodate?
"Affirmative, clinicaltrials.gov confirms that this procedure is actively seeking volunteers since its inception on December 2nd 2020. 40 individuals need to be recruited from 7 different medical sites by June 9th 2022."
Share this study with friends
Copy Link
Messenger